MEZZALANA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 299
EU - Europa 187
AS - Asia 128
Totale 614
Nazione #
US - Stati Uniti d'America 297
CN - Cina 104
IE - Irlanda 61
FI - Finlandia 25
UA - Ucraina 25
SG - Singapore 18
SE - Svezia 17
IT - Italia 14
DE - Germania 12
PT - Portogallo 12
BE - Belgio 11
GB - Regno Unito 7
JP - Giappone 4
CA - Canada 2
PL - Polonia 2
BD - Bangladesh 1
EE - Estonia 1
JO - Giordania 1
Totale 614
Città #
Chandler 64
Dublin 61
Ann Arbor 41
Jacksonville 41
Nanjing 40
Ashburn 18
Singapore 15
Boardman 14
Wilmington 14
Princeton 13
Changsha 12
Coimbra 12
Nanchang 12
Brussels 11
Helsinki 9
Lawrence 9
Medford 8
Hangzhou 7
Hebei 7
Shenyang 7
Dearborn 6
Piscataway 6
Shanghai 6
Falls Church 5
Houston 5
Pavia 4
Zhengzhou 4
Woodbridge 3
Des Moines 2
Guangzhou 2
Milan 2
Needham 2
Norwalk 2
Poznan 2
Redwood City 2
San Diego 2
Tianjin 2
Toronto 2
Amman 1
Beijing 1
Dallas 1
Dhaka 1
Jiaxing 1
Lanzhou 1
San Jose 1
Seattle 1
Taizhou 1
Tallinn 1
Tappahannock 1
Tokyo 1
Totale 486
Nome #
A Target-Mediated Drug Disposition model to quantify the relationship between Otelixizumab in vitro concentration and TCR/CD3 engagement 84
A Target-Mediated Drug Disposition model integrated with a T lymphocyte pharmacodynamic model for Otelixizumab. 81
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases. 77
Temporal pharmacokinetic/pharmacodynamic interaction between human CD3ε antigen-targeted monoclonal antibody otelixizumab and CD3ε binding and expression in human peripheral blood mononuclear cell static culture 73
Multinomial Logistic Functions in Markov Chain Models of Sleep Architecture: Internal and External Validation and Covariate Analysis 71
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 71
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter 70
Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development 60
MPBPK-TMDD models for mAbs: alternative models, comparison, and identifiability issues 41
Totale 628
Categoria #
all - tutte 2.421
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.421


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202032 0 0 0 0 0 8 3 8 1 11 0 1
2020/202176 8 4 3 8 2 7 6 9 6 12 9 2
2021/202269 2 2 4 2 4 3 4 6 1 7 8 26
2022/2023176 21 21 4 24 13 14 0 5 67 1 4 2
2023/202464 3 10 0 1 18 9 6 1 2 0 11 3
2024/202538 6 12 0 8 5 7 0 0 0 0 0 0
Totale 628